|
|
|
| Effect of Ginkgo Biloba Extract Injection combined with Cinepazide Maleate in the treatment of sudden deafness |
| ZHANG Hongjie HUO Yan WANG Shanshan |
| Otolaryngology Head and Neck Surgery, Panjin Central Hospital, Liaoning Province, Panjin 124010, China |
|
|
|
Abstract Objective To explore clinical effect and safety of Ginkgo Biloba Extract Injection combined with Cinepazide Maleate in the treatment of sudden deafness (SD). Methods From January 2017 to January 2019, 102 cases of SD patients admitted to Panjin Central Hospital of Liaoning Provimce, according to the random number table method, which were divided into control group (51 cases) and observation group (51 cases). The control group was treated with Cinepazide Maleate, and the observation group was treated with Ginkgo Biloba Extract Injection on the basis of the control group. The two groups were treated for 2 weeks. Clinical efficacy was evaluated after treatment. The hearing threshold levels, peripheral blood levels of CD3+, CD4+, CD8+, CD4+/CD8+ and the levels of serum endothelin (ET), soluble vascular cell adhesion molecule (sVCAM), tumor necrosis factor-α (TNF-α), interleukin-8 (IL-8), matrix metalloproteinase-9 (MMP-9) of the two groups were compared before and after treatment. The adverse reactions of the two groups during the treatment were recorded and compared. Results The total clinical effective rate of the observation group was significantly higher than the control group (P ＜ 0.05). The hearing threshold levels of the two groups after treatment were significantly lower than before treatment (P ＜ 0.05), and the observation group was significantly lower than that of the control group (P ＜ 0.05). The peripheral blood levels of CD3+, CD4+ and CD4+/CD8+ of the two groups after treatment were significantly higher than before treatment (P ＜ 0.05), the peripheral blood levels of CD8+ were significantly lower than before treatment (P ＜ 0.05), while CD3+, CD4+ and CD4+/CD8+ of the observation group were significantly higher than the control group after treatment (P ＜ 0.05), and CD8+ was significantly lower than the control group (P ＜ 0.05). The levels of serum ET, sVCAM, TNF-α, IL-8 of the two groups after treatment were significantly lower than before treatment (P ＜ 0.05), the levels of serum MMP-9 were significantly higher than before treatment (P ＜ 0.05), while ET, sVCAM, TNF-α and IL-8 in the observation group were significantly lower than the control group (P ＜ 0.05), and MMP-9 was significantly higher than the control group (P ＜ 0.05). During treatment, there was no severe adverse reaction of the two groups. Conclusion Ginkgo biloba Extract Injection combined with Cinepazide Maleate on SD has significant effect, can promote hearing, improve the immune function and inner ear microcirculation, reduce the inflammatory response, and has good safety.
|
|
|
|
|
|
[1] 高苏凯，夏轶男，文莲姬.老年突发性耳聋患者的特点及个体化治疗效果[J].中国老年学杂志，2015，35（20）：5945-4546.
[2] 李漫，杨翼.中医药治疗突发性耳聋的研究进展[J].国际中医中药杂志，2011，33（8）：750-753.
[3] 李羴，王瑜，邱丹韫，等.中西医治疗突发性耳聋的研究进展[J].广西中医药大学学报，2017，20（1）：66-69.
[4] 刘石.马来酸桂哌齐特对老年高血压患者突发性耳聋的疗效[J].中国老年学杂志，2014，34（5）：1363-1364.
[5] 于玲，徐静.银杏叶提取物治疗突发性耳聋气滞血瘀证临床研究[J].中医学报，2018，33（1）：145-148.
[6] 中华耳鼻咽喉头颈外科杂志编辑委员会，中华医学会耳鼻咽喉头颈外科学分会.突发性聋的诊断和治疗指南（2015）[J].中华耳鼻咽喉头颈外科杂志，2015，50（6）：443-447.
[7] 姜泗长，顾瑞，王正敏.耳鼻咽喉科全书：耳科学[M].2版.上海：上海科学技术出版社，2002：836.
[8] 孙亮.突发性耳聋的病因及预后因素研究进展[J].海南医学，2013，24（13）：1967-1969.
[9] 张瑾，曹刘，谢亭亭，等.中西医结合治疗突发性耳聋随机对照试验的Meta分析[J].中医眼耳鼻喉杂志，2016，6（2）：64-69.
[10] 虞娴波，殷建军.马来酸桂哌齐特治疗突发性耳聋的疗效及安全性观察[J].药物流行病学杂志，2013，22（4） ：171-172，178.
[11] 朱正尧，孙祥.马来酸桂哌齐特联合丹参川芎嗪治疗突发性耳聋疗效及对血清ET、sVCAM-1水平和免疫功能的影响[J].现代中西医结合杂志，2018，27（36）：4016-4019.
[12] 钱剑宁，程国辉，李文东.马来酸桂哌齐特治疗急性脑梗死的疗效及对神经、炎症因子水平的影响[J].中国医药科学，2019，9(13)：45-47.
[13] 徐晖，闫妍，王佳明，等.银杏叶提取物联合注射用甲泼尼龙琥珀酸钠对突发性耳聋患者听力改善及血清sVCAM-1、TXB2水平的影响[J/OL].中国现代医学杂志：1-10.
[14] 阿不都许库尔·吾买尔，王祥升，姜蕊蕊.银杏叶提取物注射液联合倍他司汀治疗突发性耳聋的疗效观察[J].现代药物与临床，2018，33（10）：2677-2680.
[15] 张弓剑，郭小平，韩治国.银杏叶提取物注射液联合桂哌齐特治疗突发性耳聋的临床研究[J].现代药物与临床，2019，34（5）：1435-1439.
[16] 王涛.外周血T细胞亚群失衡与突发性耳聋疗效的相关性研究[D].芜湖：皖南医学院，2018.
[17] 韩倩，渠晓丽，刘平，等.银杏叶提取物对突发性耳聋患者免疫功能的影响及疗效观察[J].临床误诊误治，2015， 28（2）：106-108.
[18] 温锐，王俭.银杏叶提取物的免疫调节作用研究[J].实用药物与临床，2018，21（10）：1109-1111.
[19] 衡伟伟，后婕，魏先梅，等.TNF-α和IL-8在突发性聋患者血清及外周血单个核细胞中的表达及其意义[J].山东大学耳鼻喉眼学报，2016，30（2）：41-45.
[20] 宋昱晨，朱丹.糖皮质激素治疗对大叶性肺炎患者血清中IL-6、TNF-α和IL-8含量的影响[J].中国现代医生，2017，55（11）：1-4.
[21] 卢韬，康厚墉，胡国华，等.突发性聋免疫损伤证据：MMP-9表达下调及意义[J].中华耳科学杂志，2017，15（5）：542-545.
[22] 杨明，伏飞达，朱晓燕.突发性耳聋患者血清sVCAM-1水平变化及其意义[J].中国医药导报，2018，15（15）：119-122. |
|
|
|
